Applicant, as named in the Orange Book

Uswm

Next listed expiry: Iwilfin on 12 Feb 2036. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Iwilfin NDA 215500 eflornithine hydrochloride	eflornithine hydrochloride	12 Feb 2036 patent, carve-out possible	patent, carve-out possible

Iwilfin · Exclusivity expires within 90 days NPExclusivity expires 13 Dec 2026Detected 24 Oct 2026